全球创新药VC&PE投融资情况的改善也反映了行业景气度的提升。2025年一季度，全球市场创新药投 融资增速同比明显改善，表明投资者对创新药行业的前景持乐观态度，愿意投入更多资金支持创新药的 研发和商业化。 AI技术在创新药研发中的应用日益广泛，大大提高了新药研发的效率和成功率。例如，可以用于药物 筛选、分子设计、临床试验设计等多个环节，缩短研发周期，降低研发成本，这为创新药企业带来新的 增长动力。 随着人口老龄化程度的不断加深和健康意识的提高，市场对创新药的需求持续增长。特别是在肿瘤、罕 见病、慢性病等领域，创新药的市场需求尤为旺盛，这为创新药企业提供了广阔的市场空间和发展机 遇。 ◎农银汇理基金经理 梦圆 2023年以来，我们持续增配创新药板块。今年一季度，我们的医药基金对创新药的持仓配置已至历史较 高水平。一个需要和投资者交流的问题是：我们为什么如此看好创新药行业？ 从国内政策面来看，国家对创新药板块的支持力度持续加大，相关政策陆续出台并落地。例如，加快新 药审批流程、提供税收优惠、设立专项基金支持、扩大商保等支付途径。这些政策不仅提升了国内创新 药企业的研发积极性，还增强了市场信心。 从国内行业基本面来 ...

Group 1: Company Performance and Market Opportunities - The company reported significant growth in the sanitary napkin segment, with a market size in China exceeding 100 billion RMB, indicating vast growth potential despite being a relatively small player [5] - The aging population and increasing health management needs are driving demand for medical supplies, creating a larger market space for the company [2] - The company aims to enhance its market competitiveness by focusing on disposable medical supplies through acquisitions and expanding its product categories [2] Group 2: Strategic Initiatives - The company is committed to providing integrated solutions for hospitals, pharmacies, and home care, addressing pain points in quality, supply chain, and digital integration [2] - Continuous investment in R&D is prioritized to innovate products that fill market gaps and meet patient and healthcare institution needs [2] - The company is advancing smart manufacturing and AI technology applications to improve production efficiency and reduce costs [2] Group 3: Channel Strategy and Growth Projections - The medical segment's channel strategy includes overseas business, domestic hospital lines, consumer medical business, and cross-border e-commerce, with a focus on significant growth in domestic hospital lines in 2025 [9][10] - The overseas business is primarily focused on Europe, while the domestic hospital segment is being segmented into traditional dressings, surgical materials, and high-end dressings [9] - The cross-border e-commerce channel has been the fastest-growing, particularly on platforms like Amazon, despite potential impacts from current tariff policies [10] Group 4: Impact of Tariff Policies - The company anticipates limited impact from U.S. tariff policies, with affected sales in overseas divisions and cross-border e-commerce remaining in single-digit percentages of the medical segment [6][7] - Strategies to mitigate tariff impacts include increasing investments in South America and expanding existing U.S. operations [6][7] - The company maintains strong competitive advantages in the U.S. market for medical supplies, with various strategies to manage tariff-related challenges [7] Group 5: Brand Management and Investor Relations - The company has implemented a market value management system to protect and return value to investors, with regular monitoring against industry benchmarks [11] - A rising trend in dividend payouts has been established, with plans for mid-year dividends starting in 2024 [11] - The company emphasizes transparency and communication with investors, enhancing information disclosure and hosting performance briefings [11] Group 6: Product Development and Consumer Engagement - The company is focusing on product innovation in the sanitary napkin sector, utilizing high-quality cotton and advanced technologies to enhance user experience [5] - Initiatives to improve consumer trust include product traceability through QR codes and real-time factory monitoring [14][15] - The company is actively engaging with consumers for feedback on product improvements, integrating suggestions into new product developments [14]

2025 年 5 月 8 日 行业研究 业绩实现高增长，光模块、北斗导航、AI 供应链景气度较高 ——通信行业 2024 年年报及 2025 年一季报总结 通信行业 增持（维持） 作者 分析师：刘凯 执业证书编号：S0930517100002 021-52523849 kailiu@ebscn.com 分析师：林仕霄 执业证书编号：S0930522090003 021-52523818 linshixiao@ebscn.com 分析师：朱宇澍 执业证书编号：S0930522050001 021-52523821 zhuyushu@ebscn.com 分析师：王之含 执业证书编号：S0930524070008 021-52523691 wangzhihan@ebscn.com 行业与沪深 300 指数对比图 -14% -1% 12% 25% 38% 05/24 07/24 11/24 02/25 通信行业 沪深300 资料来源：Wind 要点 2025 年一季度通信行业整体业绩实现高增长，其中光模块、北斗导航、AI 供应链 表现亮眼。2024 年通信全行业（A 股）170 家公司实现归母净利润 2082.91 ...

2025 年一季度欧派家居的业绩表现如何？ 摘要 欧派家居 20250507 • 欧派家居 2024 年营收 189.3 亿元，同比下降 16.9%，归母净利润 26 亿 元，同比下降 14.4%。2025 年一季度营收 34.5 亿元，同比下降 4.8%， 但归母净利润同比增长 41%至 3.1 亿元，毛利率达 34.3%，为历史同期 最高，受益于家居消费补贴政策。 • 经销渠道营收 140.4 亿元，同比下降 20%，但零售大家居有效店面增至 1,100 余家。工程渠道营收 30.5 亿元，同比下降 15%，但非地产项目业 务量增长近 50%。直营和海外渠道分别增长 20%和 34%，营收分别为 8.3 亿元和 4.3 亿元。 • 公司通过建立大宗材料价格动态监测机制、优化供应体系、加快智能制造、 精简产品 SKU、应用新材料新工艺、动态调整激励机制等措施，有效控制 成本，使得 2024 年毛利率达 35.9%，同比上升 1.76 个百分点。 • 公司计划未来三年以总股本为基数，每年每股派发现金红利 2.48 元，预 计年度派发现金红利 15 亿元，占报告期归母净利润的 58%，并计划在 2025 年度增 ...

风险提示：地缘政治，新品研发及市场拓展不及预期等。 事件：2024 年，公司实现营业收入6.45 亿元（括号内为同比，下同，+18.65%），归母净利润1.24 亿元 （-19.38%）；2024Q4 单季度营收1.82亿元（+38.50%），归母净利润40.34 百万元（+58.63%）。 2025Q1 营收1.86 亿元（+27.73%），归母净利润40.58 百万元（+32.31%）。 投资要点 盈利预测与投资评级：考虑行业复苏及公司紧抓行业机会，我们将公司2025-2026 年营收从7.99/9.59 亿 元上调至8.01/9.70 亿元，同时考虑公司仍处于研发及销售投入阶段，将归母净利润从2.16/2.70 亿元下 调至1.61/2.16 亿元，我们预测2027 年营收和归母净利润分别为11.59亿元和2.64 亿元，当前股价对应 2025-2027 年PE 分别为36/27/22×，维持"买入"评级。 24Q4 拐点已过，收入规模效应逐渐显现：剔除新冠影响后，公司2024年营收6.2 亿元（+24%）。分地 区来看，2024 年国内营收2.16 亿元（+16.8%）；国外营收4.29 亿元（+19 ...

Core Insights - The company, Zhangyue Technology, reported a total revenue of 2.583 billion yuan for 2024, a slight decline of 7.02% year-on-year, while the net profit attributable to shareholders reached 49.2917 million yuan, an increase of 41.46% year-on-year [1][30] - The revenue from derivative businesses, particularly micro-short dramas, surged to 776 million yuan, marking a significant growth of 189.99% year-on-year, and accounting for 30% of the total revenue, establishing it as the company's "second growth curve" [2][30] - In the first quarter of 2025, the company achieved a revenue of 643 million yuan, a decrease of 5.19% year-on-year, with a net loss attributable to shareholders of 74.28 million yuan [2][6] Financial Overview - For 2024, the company reported total revenue of 2.583 billion yuan, a year-on-year decrease of 7.02%, and a net profit of 49.2917 million yuan, reflecting a year-on-year increase of 41.46% [2][30] - The cash flow from operating activities was negative at -75.017 million yuan, a decrease of 413 million yuan year-on-year, primarily due to significant investments in derivative businesses and AI technology applications [5] - The sales expenses for 2024 were approximately 1.5 billion yuan, down 11.86% year-on-year, while R&D expenses were around 200 million yuan, also down 11.51% year-on-year [5] Business Segment Performance - The digital reading platform revenue fell to 1.647 billion yuan, a decline of 25.91% year-on-year, while derivative business revenue reached 776 million yuan, a substantial increase of 189.99% [5][30] - The copyright product revenue decreased to 158 million yuan, down 39.53% year-on-year, and other business revenue dropped to 2.9784 million yuan, down 88.92% [5] - The short drama business has become the company's largest segment, focusing on young audiences with themes such as romance, campus life, and workplace scenarios [6][31] Domestic and International Expansion - The company has developed 1,304 micro-short dramas in the domestic market, achieving a cumulative heat value of 75.4 million, with seven dramas exceeding a heat value of 10 million [7][12] - In the overseas market, the iDrama platform has added nearly 200,000 users since its launch, with a total revenue of approximately 365,600 USD (about 2.665 million yuan) and over 190,000 downloads [15][18] - The iDrama platform is primarily focused on the U.S. market, which accounts for 53.87% of its revenue, while the Philippines, Japan, and Malaysia follow [18]

Core Insights - The company reported a revenue of 2.87 billion in 2024, a year-on-year increase of 0.96%, and a net profit attributable to shareholders of 500 million, a year-on-year increase of 0.2% [1] - In Q1 2025, the company achieved a revenue of 740 million, a year-on-year increase of 5.1%, and a net profit attributable to shareholders of 180 million, a year-on-year increase of 6.2% [1] Revenue Breakdown - The revenue from planting reached 530 million, accounting for 19.4% of total revenue, with a year-on-year increase of 10.6% [1] - Orthodontics generated revenue of 470 million, accounting for 17.3% of total revenue, with a year-on-year decrease of 5.1% [1] - Pediatric services generated revenue of 500 million, accounting for 18.3% of total revenue, with a year-on-year increase of 0.3% [1] - Restoration services generated revenue of 460 million, accounting for 16.9% of total revenue, with a year-on-year increase of 1.5% [1] - Comprehensive services generated revenue of 760 million, accounting for 28.0% of total revenue, with a year-on-year increase of 1.3% [1] Profitability Metrics - The overall gross margin for medical services in 2024 was 39.3%, reflecting a decline of 0.09 percentage points compared to 2023 due to factors such as centralized procurement of dental implants and consumer downgrade [1] Expense Management - The company maintained good control over expense ratios, with a 2024 expense ratio of 15.8%, an increase of 0.2 percentage points year-on-year [2] - In Q1 2025, the expense ratio was 13.5%, with a sales expense ratio of 0.9%, management expense ratio of 9.8%, R&D expense ratio of 1.6%, and financial expense ratio of 1.2% [2] - The company has implemented various digital operations and AI technologies to enhance overall operational efficiency [2] Earnings Forecast - The expected EPS for 2025, 2026, and 2027 are projected to be 1.13, 1.20, and 1.28 respectively [3]

文章来源 报告导读： 粮价影响种植板块业绩。2025年看好粮价触底回升，叠加关税影响之下，我 国进口农产品有望进一步减少，催生粮食安全自主可控背景下的种植板块投资机会。 2024 年 &2025Q1 ，玉米大豆等粮价先跌后涨。 2024 年全年玉米、豆粕、小麦、棉粕等农产品价格整 体下行。 2025Q1 粮价开启上行通道，玉米现货季末价格较季初增长 6.4% ，豆粕现货季末价格较季初 增长 6.5% ，小麦现货季末价格较季初增长 1.2% ，棉粕出厂价（山东）季末价格较季初增长 18.4% 。 粮价影响农产品相关公司业绩，看好 2025 景气提升。 2025Q1 棉粕价格上涨，晨光生物业绩回升明 显。往后看，玉米、大豆、小麦价格有望保持相对景气上涨态势，带动农产品相关公司经营业绩进一步改 善。 关税调整，粮食进口减少，推动自主可控。 2025 年 4 月，我国对美国关税霸权进行反制，美国是中国 的第二大粮食进口来源地， 2024 年中国自美国进口农产品的规模为 249 亿美元。我们认为，中国自美 国进口农产品有望进一步降低，推动国内粮价景气度提升，利好种植产业链。与此同时，粮食自主可控势 在必行，科技应用推广 ...

2025起点 轻型动力电池 技术 高峰 论坛 2025第五届起点两轮车换电大会 聚焦轻型电池技术 拓展新兴应用市场 时间： 7月10-11日 地点：江苏无锡 一、活动背景及亮点 二、活动组织架构 起点研究院（ SPIR）轻型动力电池及两轮车换电TOP排行榜权威发布（覆盖 中国轻型动力 电池出货量TOP20，中国中小储能电池出货量TOP20、无人机电池/电动工具电池/两轮车 电池关键细分环节出货量TOP10、锂电电动两轮车/两轮车换电运营商TOP10 等），为行 业树立标杆，为投资及采购决策者提供参考； 海内外轻型动力及中小储能市场高速增长，低空飞行、移动电动工具、人形/智能机器人、 智能家居、智慧储能等热门应用场景进入高速发展期，新一轮增量市场推动电池技术迭代革 新； 政策支持、即时配送需求及技术升级等主要驱动力影响下，全球两轮车换电市场高速增长， 基于产业链整合优势，中国企业将迎来新一轮布局风口，电池安全、下沉市场覆盖及成本优 化等挑战急需解决； 上下游企业加速研发高安全、高倍率、高能量密度、长循环寿命、低成本、高低温等细分性 能优势电池产品； AI技术加速驱动固态、钠电、全极耳等新电池技术与工艺体系的研发 ...

Ethan Allen Interiors (ETD) Q3 2025 Earnings Call May 05, 2025 05:00 PM ET Company Participants Matt McNulty - Senior VP, Treasurer & CFOFarooq Kathwari - Chairman, President & CEOBrad Thomas - Associate Director of Research Conference Call Participants Cristina Fernández - Managing Director & Senior Equity Research Analyst Operator Good afternoon, and welcome to the Ethan Allen Fiscal twenty twenty five Third Quarter Analyst Conference Call. At this time, all participants are in a listen only mode. A quest ...